Analyst upgrades typically lead to a positive short-term reaction in the stock market as they reflect a positive change in the analyst's view of the company's future performance. Given that this upgrade is from a reputable firm like Argus Research, it's likely to influence investors' perceptions positively, potentially driving up the stock price of Cardinal Health in the short term.